UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Xofigo combinations raise fracture risk
Combinations using Bayer Korea’s prostate cancer treatment Xofigo Inj. (ing...
by Lee Hye-seon
|
2018-07-19 13:59
라인
‘Medidata can shorten new drug development by 6 months’
“If you use Medidata’s solution, you can shorten the time of new drug devel...
by Lee Hye-seon
|
2018-07-11 13:56
라인
Ban of antihypertensive drug puts Korean drugmakers in panic
The government’s ban of 128 antihypertensive drugs using valsartan manufact...
by Lee Hye-seon/Nam Doo-hyun
|
2018-07-09 16:24
라인
Generic copies of Avodart ready to hit market
Local pharmaceutical companies are preparing to release generic copies of A...
by Lee Hye-seon
|
2018-07-05 14:58
라인
Severance Hospital robotic surgeries hit 20,000
Severance Hospital said it has performed 20,000 robotic surgeries, the most...
by Lee Hye-seon
|
2018-07-02 11:53
라인
Weight-loss drug Saxenda creates marketing sensation in Korea
Saxenda (ingredient: liraglutide), an injectable drug to treat obesity, is ...
by Lee Hye-seon
|
2018-06-28 16:40
라인
Hepatitis B reactivation added to Simulect precautions
The government said it has ordered Novartis to add “hepatitis B reactivatio...
by Lee Hye-seon
|
2018-06-28 12:20
라인
Il-yang’s antianginal drug found with excessive lead
The government said it has banned the sale of Il-yang Pharmaceutical’s anti...
by Lee Hye-seon
|
2018-06-26 12:12
라인
Safety of heat-not-burn tobacco still controversial
The fight between the Ministry of Food and Drug Safety and the tobacco indu...
by Lee Hye-seon
|
2018-06-19 15:41
라인
Will Yervoy+Cemiplimab combo fight non-small cell lung cancer?
A global phase-2 clinical trial will soon take place in Korea to check if a...
by Lee Hye-seon
|
2018-06-11 15:11
라인
Sanofi Pasteur loses license for flu vaccine IDflu
Sanofi Pasteur has lost local approval for its intradermal influenza vaccin...
by Lee Hye-seon
|
2018-06-07 10:52
라인
‘Electronic consent will transform patient experience in clinical trials’
Celebrating the 20th anniversary this year, the Korea Cancer Study Group (K...
by Lee Hye-seon
|
2018-05-29 14:44
라인
Stick-on fever indicators to be available at supermarkets
Stick-on fever indicators that change colors according to body temperatures...
by Lee Hye-seon
|
2018-05-28 15:59
라인
‘Medical animation improves patient’s informed consent’
There is an Asian proverb saying “it is better to see something once than t...
by Lee Hye-seon
|
2018-05-22 15:34
라인
Antidiabetic drug linagliptin had 313 adverse events in 6 years
Type-2 antidiabetic treatment Linagliptin has had a 7.69 percent incidence ...
by Lee Hye-seon
|
2018-05-21 14:33
라인
Pineapple extract gel approved for burns
Nexoberide Gel, a treatment that removes dead skin tissues caused by burns,...
by Lee Hye-seon
|
2018-05-19 08:19
라인
GSK’s 3-in-1 inhaler for COPD arrives in Korea
GlaxoSmithKline’s triple drug inhaler for the treatment of chronic obstruct...
by Lee Hye-seon
|
2018-05-14 14:54
라인
Daewoong, CJ, Jeil win nod for combo drug for dyslipidemia, diabetes
Daewoong Pharmaceutical, CJ Healthcare, and Jeil Pharmaceutical have won th...
by Lee Hye-seon
|
2018-05-11 14:37
라인
Dong-A ST wins nod for testing overactive bladder treatment
The Ministry of Food and Drug Administration said it has approved Dong-A ST...
by Lee Hye-seon
|
2018-05-10 13:30
라인
Daewoong compares Nabota with Botox in US, Mexico
Daewoong Pharmaceutical is actively promoting Nabota, an injectable type A ...
by Lee Hye-seon
|
2018-05-04 14:27
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top